Article
The analysis of JAK2 and MPL mutations and JAK2 single nucleotide polymorphisms in MPN patients by MassARRAY assay.
International journal of laboratory hematology - 1 Aug 2010
Zhang S-J, Qiu H-X, Li J-Y, Shi J-Y, Xu W
Abstract excerpt
Recent studies have shown that JAK2 V617F, MPL W515L/K and JAK2 exon 12 mutations underlie the major molecular pathogenesis of myeloproliferative disorders (MPN). Allele-Specific Polymerase Chain Reaction (AS-PCR), direct sequencing and MassARRAY assay were used to ascertain the real prevalence of these mutations and the influence of genetic susceptibility in Chinese MPN patients. The positive rate of JAK2 V617F...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
